Brendan Antiochos is a Rheumatology/Immunology physician affiliated with Johns Hopkins University. OpenAlex indexes 63 publications with 1,886 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4940 Eastern Ave
Baltimore, MD 212242735
Telephone
410-550-5624Provider last certified this registry record 27 Mar 2025.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
39.5%Corticosteroid33.6%Prednisone100%Part D≥20 patientsH2 blocker5.9%Famotidine100%Part D<11 patientsCancer & immunology
31.8%Folate Analog Metabolic Inhibitor15%Methotrexate100%Part D≥14 patientsInterleukin-6 Receptor Antagonist10.5%Actemra Actpen100%Part D<11 patients+ 1 more class in this area
Nervous system
12.7%Gabapentinoids12.7%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Mechanisms of XIST-TLR7 Signaling in Sjogren's Disease
Johns Hopkins University
FY2026$464,180R01DE035882 - The Retroelement LINE1 and the DNA Sensor IF16 in Sjogren's Syndrome
Johns Hopkins University
FY2025$158,755K08AR077100 - Delineating the interplay between nucleic-acid-dependent phase separation and immune responses against cGAS in SLE
Johns Hopkins University
FY2024$375,100R21AR085266
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Protein•DNA Mesh Assembly Drives dsDNA-Specific and Duplex Length-Dependent Activation of cGAS
SSRN Electronic Journal
2026 - Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis
Kidney International Reports
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”